A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...

Some tumor types spread throughout the body and develop metastases instead of staying at their original location.

In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

1 Department of Clinical Science and Education, Karolinska Institute at South Hospital, Stockholm, Sweden 2 Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden Background ...

Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases ...

Six normal human volunteers as renal transplant donors were given 3 H-digoxin before and again after unilateral nephrectomy. The serum digoxin concentration was modestly increased following ...

Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases. This is ...